Logo image of GIN.DE

GIVAUDAN-REG (GIN.DE) Stock Fundamental Analysis

Europe - FRA:GIN - CH0010645932 - Common Stock

3635 EUR
+120 (+3.41%)
Last: 10/8/2025, 7:00:00 PM
Fundamental Rating

6

GIN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 71 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making GIN a very profitable company, without any liquidiy or solvency issues. GIN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

GIN had positive earnings in the past year.
In the past year GIN had a positive cash flow from operations.
In the past 5 years GIN has always been profitable.
Each year in the past 5 years GIN had a positive operating cash flow.
GIN.DE Yearly Net Income VS EBIT VS OCF VS FCFGIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 9.01%, GIN belongs to the top of the industry, outperforming 88.73% of the companies in the same industry.
Looking at the Return On Equity, with a value of 23.81%, GIN belongs to the top of the industry, outperforming 97.18% of the companies in the same industry.
GIN has a Return On Invested Capital of 13.14%. This is amongst the best in the industry. GIN outperforms 92.96% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GIN is above the industry average of 6.85%.
The last Return On Invested Capital (13.14%) for GIN is above the 3 year average (11.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROIC 13.14%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
GIN.DE Yearly ROA, ROE, ROICGIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of GIN (14.71%) is better than 92.96% of its industry peers.
In the last couple of years the Profit Margin of GIN has grown nicely.
Looking at the Operating Margin, with a value of 18.96%, GIN belongs to the top of the industry, outperforming 90.14% of the companies in the same industry.
GIN's Operating Margin has improved in the last couple of years.
GIN has a better Gross Margin (44.13%) than 64.79% of its industry peers.
GIN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
GIN.DE Yearly Profit, Operating, Gross MarginsGIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GIN is creating value.
Compared to 1 year ago, GIN has about the same amount of shares outstanding.
GIN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for GIN has been reduced compared to a year ago.
GIN.DE Yearly Shares OutstandingGIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
GIN.DE Yearly Total Debt VS Total AssetsGIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

GIN has an Altman-Z score of 4.43. This indicates that GIN is financially healthy and has little risk of bankruptcy at the moment.
GIN's Altman-Z score of 4.43 is amongst the best of the industry. GIN outperforms 87.32% of its industry peers.
The Debt to FCF ratio of GIN is 3.57, which is a good value as it means it would take GIN, 3.57 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 3.57, GIN belongs to the best of the industry, outperforming 87.32% of the companies in the same industry.
A Debt/Equity ratio of 0.86 indicates that GIN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.86, GIN is doing worse than 73.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Altman-Z 4.43
ROIC/WACC2.86
WACC4.59%
GIN.DE Yearly LT Debt VS Equity VS FCFGIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.49 indicates that GIN should not have too much problems paying its short term obligations.
GIN has a worse Current ratio (1.49) than 60.56% of its industry peers.
A Quick Ratio of 0.98 indicates that GIN may have some problems paying its short term obligations.
The Quick ratio of GIN (0.98) is comparable to the rest of the industry.
The current and quick ratio evaluation for GIN is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.98
GIN.DE Yearly Current Assets VS Current LiabilitesGIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

4

3. Growth

3.1 Past

GIN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.21%.
Measured over the past 5 years, GIN shows a small growth in Earnings Per Share. The EPS has been growing by 6.04% on average per year.
GIN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.93%.
The Revenue has been growing slightly by 3.63% on average over the past years.
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%

3.2 Future

GIN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.29% yearly.
GIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.53% yearly.
EPS Next Y3.67%
EPS Next 2Y4.22%
EPS Next 3Y5.1%
EPS Next 5Y5.29%
Revenue Next Year1.56%
Revenue Next 2Y2.39%
Revenue Next 3Y3.29%
Revenue Next 5Y4.53%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GIN.DE Yearly Revenue VS EstimatesGIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
GIN.DE Yearly EPS VS EstimatesGIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50 100 150

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.07 indicates a quite expensive valuation of GIN.
Compared to the rest of the industry, the Price/Earnings ratio of GIN is on the same level as its industry peers.
When comparing the Price/Earnings ratio of GIN to the average of the S&P500 Index (27.70), we can say GIN is valued inline with the index average.
The Price/Forward Earnings ratio is 25.02, which means the current valuation is very expensive for GIN.
GIN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. GIN is more expensive than 60.56% of the companies in the same industry.
GIN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.15.
Industry RankSector Rank
PE 27.07
Fwd PE 25.02
GIN.DE Price Earnings VS Forward Price EarningsGIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GIN is valued a bit more expensive than the industry average as 69.01% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, GIN is valued a bit cheaper than 71.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.44
EV/EBITDA 19.7
GIN.DE Per share dataGIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GIN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of GIN may justify a higher PE ratio.
PEG (NY)7.37
PEG (5Y)4.48
EPS Next 2Y4.22%
EPS Next 3Y5.1%

5

5. Dividend

5.1 Amount

GIN has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
GIN's Dividend Yield is a higher than the industry average which is at 3.05.
Compared to an average S&P500 Dividend Yield of 2.44, GIN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

The dividend of GIN has a limited annual growth rate of 2.07%.
Dividend Growth(5Y)2.07%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

GIN pays out 57.52% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of GIN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP57.52%
EPS Next 2Y4.22%
EPS Next 3Y5.1%
GIN.DE Yearly Income VS Free CF VS DividendGIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIN.DE Dividend Payout.GIN.DE Dividend Payout, showing the Payout Ratio.GIN.DE Dividend Payout.PayoutRetained Earnings

GIVAUDAN-REG

FRA:GIN (10/8/2025, 7:00:00 PM)

3635

+120 (+3.41%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-14 2025-10-14
Inst Owners34.16%
Inst Owner ChangeN/A
Ins Owners12.15%
Ins Owner ChangeN/A
Market Cap33.55B
Analysts72.41
Price Target4290.16 (18.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend72.73
Dividend Growth(5Y)2.07%
DP57.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.99%
PT rev (3m)-3.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.4%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-2.46%
Valuation
Industry RankSector Rank
PE 27.07
Fwd PE 25.02
P/S 4.21
P/FCF 23.44
P/OCF 19.21
P/B 6.82
P/tB N/A
EV/EBITDA 19.7
EPS(TTM)134.27
EY3.69%
EPS(NY)145.31
Fwd EY4%
FCF(TTM)155.09
FCFY4.27%
OCF(TTM)189.21
OCFY5.21%
SpS863.01
BVpS533.04
TBVpS-29.11
PEG (NY)7.37
PEG (5Y)4.48
Profitability
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROCE 15.16%
ROIC 13.14%
ROICexc 14.32%
ROICexgc 33.12%
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
FCFM 17.97%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
ROICexc(3y)12.12%
ROICexc(5y)11.56%
ROICexgc(3y)26.36%
ROICexgc(5y)25.23%
ROCE(3y)13.03%
ROCE(5y)12.58%
ROICexcg growth 3Y11.26%
ROICexcg growth 5Y9.01%
ROICexc growth 3Y9.76%
ROICexc growth 5Y7.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Debt/EBITDA 2.23
Cap/Depr 81.62%
Cap/Sales 3.95%
Interest Coverage 15.27
Cash Conversion 92.12%
Profit Quality 122.2%
Current Ratio 1.49
Quick Ratio 0.98
Altman-Z 4.43
F-Score7
WACC4.59%
ROIC/WACC2.86
Cap/Depr(3y)97.93%
Cap/Depr(5y)83.59%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.45%
Profit Quality(3y)99.97%
Profit Quality(5y)111.02%
High Growth Momentum
Growth
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
EPS Next Y3.67%
EPS Next 2Y4.22%
EPS Next 3Y5.1%
EPS Next 5Y5.29%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%
Revenue Next Year1.56%
Revenue Next 2Y2.39%
Revenue Next 3Y3.29%
Revenue Next 5Y4.53%
EBIT growth 1Y25.45%
EBIT growth 3Y8.37%
EBIT growth 5Y8.14%
EBIT Next Year28.87%
EBIT Next 3Y12.05%
EBIT Next 5Y10.03%
FCF growth 1Y45.57%
FCF growth 3Y8.88%
FCF growth 5Y10.3%
OCF growth 1Y18.35%
OCF growth 3Y8.06%
OCF growth 5Y7.42%